Edwards Lifesciences (EW) Retained Earnings (2016 - 2025)
Edwards Lifesciences (EW) has 17 years of Retained Earnings data on record, last reported at $14.2 billion in Q4 2025.
- For Q4 2025, Retained Earnings rose 8.15% year-over-year to $14.2 billion; the TTM value through Dec 2025 reached $14.2 billion, up 8.15%, while the annual FY2025 figure was $14.2 billion, 8.15% up from the prior year.
- Retained Earnings reached $14.2 billion in Q4 2025 per EW's latest filing, up from -$250.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $14.2 billion in Q4 2025 and bottomed at -$264.1 million in Q2 2025.
- Average Retained Earnings over 5 years is $4.9 billion, with a median of $5.3 billion recorded in 2021.
- Peak YoY movement for Retained Earnings: crashed 104.47% in 2022, then skyrocketed 5522.98% in 2024.
- A 5-year view of Retained Earnings shows it stood at $6.1 billion in 2021, then grew by 25.08% to $7.6 billion in 2022, then tumbled by 103.2% to -$242.8 million in 2023, then surged by 5522.98% to $13.2 billion in 2024, then rose by 8.15% to $14.2 billion in 2025.
- Per Business Quant database, its latest 3 readings for Retained Earnings were $14.2 billion in Q4 2025, -$250.4 million in Q3 2025, and -$264.1 million in Q2 2025.